Quantitative evaluation of DSS-induced colitis with AI: a new tool to assess drug candidates for IBDAccess now
Dr. Bui is a Professor of Pathology and the Scientific Director of Analytic Microscopy Core at Moffitt Cancer Center in the United States. She was the President of the Digital Pathology Association in 2019. She is recognized as an impactful leader in pathology. Dr. Bui's expertise ranges from sarcoma pathology, cytopathology, digital pathology, and cancer biomarker testing.
Dr. Madabhushi is an endowed Professor of Biomedical Engineering at Case Western Reserve University in Cleveland, Ohio in the United States and also serves as the Director of the University’s Center for Computational Imaging and Personalized Diagnostics (CCIPD). He is also a Research Scientist at the Louis Stokes Cleveland Veterans Administration (VA) Medical Center and holds an affiliate appointment at the Cleveland Clinic.
Dr. Yagi is the Director of Pathology Digital Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in New York in the United States. She received her PhD from Tokyo Medical University in Japan and soon after won a Nikon Fellowship for two research years in teleradiology and pathology at Georgetown University, Washington, D.C. in the United States.
Professor Knowles is a global opinion leader in personalized medicine. He is currently a visiting Professor in Personalized Health Care at FIMM (Institute for Molecular Medicine Finland) at the University of Helsinki and a visiting Professor at the University of Oxford, UK. He also serves on the boards of a number of biotech companies and major academic centres. Most notably he was the President of Group Research for the Roche Group for 12 years until 2010 and more recently the Chairman of the Board of both Adaptimmune Ltd and Immunocore Ltd.